Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.

Front Pharmacol

School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.

Published: December 2023

The text refers to a correction made to a specific article identified by its DOI number (10.3389/fphar.2021.645140).
The correction likely addresses errors or updates in the content of the original article, which was published in the journal "Frontiers in Pharmacology."
This correction is important for maintaining the accuracy and reliability of the information presented in academic research.

[This corrects the article DOI: 10.3389/fphar.2021.645140.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10765582	PMC
http://dx.doi.org/10.3389/fphar.2023.1297863	DOI Listing

Publication Analysis

corrigendum inhibitory

inhibitory effects

effects rhaponticin

rhaponticin osteoclast

osteoclast formation

formation resorption

resorption targeting

targeting rankl-induced

rankl-induced nfatc1

nfatc1 ros

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!